Pratteln, Switzerland, February 27, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announces that the Spanish Interministerial Commission on Prices of Medicines, has proposed to include AGAMREE® ...

Early diagnosis of rare diseases in children can significantly improve treatment outcomes and quality of life. Learn symptoms, challenges, and why early detection is crucial for managing pediatric ...

Pratteln, Switzerland, February 27, 2026 - Santhera Pharmaceuticals (SIX: SANN) today announces that the Spanish Interministerial Commission on Prices of Medicines, has proposed to include AGAMREE (va ...

NORTH YORK, ON - February 25, 2026 - PRESSADVANTAGE - Osteo Tuina has announced that its primary service, Registered ...

As policies promise support and courts intervene, thousands of rare disease patients remain trapped between soaring drug ...

The Brown County School Board met Feb. 16 and heard a presentation from a former student about a proposed research project, ...

For years, ligament tears have been a crisis among young athletes — even though a few simple exercises can prevent them.

February 17, 2026 - PRESSADVANTAGE - Chiropractor Evansville has announced an expanded emphasis on back pain relief ...

Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...

Growing tissues can crack, break, and dissociate to form structures that can later withstand immense forces.

Through its Strategy To Accelerate Research (CMTA-STAR), CMTA is supporting four complementary approaches to overcome treatment delivery barriers with an investment of $523,000 and related support.

Gemma Biotherapeutics ("GEMMABio"), a clinical‑stage global genetic medicines company, announced today that the first patient has been dosed in the Phase 1/2 CHARISMA clinical trial of GB221, an ...